Rifaximin for the prevention of spontaneous bacterial peritonitis

21Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

According to a review article by Biecker et al published in a previous issue of World Journal of Gastroenterology in March 2011, intestinal decontamination with norfloxacin remains the mainstay of primary prophylaxis of spontaneous bacterial peritonitis (SBP) at the expense of development of quinolone-resistant bacteria after long-term use. In our research, the administration of a 4-wk regimen with rifaximin 1200 mg/d reduced significantly the ascitic neutrophil count in cirrhotic patients with sterile ascites in line with a significant decrease in plasma endotoxin levels. Our observations concur with recent findings, showing a significantly reduced 5-year probability of SBP in cirrhotic patients taking rifaximin. © 2012 Baishideng. All rights reserved.

Cite

CITATION STYLE

APA

Kalambokis, G. N., Mouzaki, A., Rodi, M., & Tsianos, E. V. (2012). Rifaximin for the prevention of spontaneous bacterial peritonitis. World Journal of Gastroenterology. Baishideng Publishing Group Co. https://doi.org/10.3748/wjg.v18.i14.1700

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free